Back to UBS Group AG UBS Group AG

MDCXMDCX
6 quarters

Position history for UBS Group AGUBS Group AG's holdings in MEDICUS PHARMA LTD

No. Ubs exited its MDCX (Medicus Pharma) position in Q2 2026. Its Q1 2026 13F listed 40,441 shares worth $18,563. Ubs first reported MDCX in Q1 2025 and held it in 5 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$79,095

Total Shares Change

-21,262

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$22.30
0
2026-Q1
Increased
40,441
+205.7%
$18,5630.0%$22.95
20
2025-Q4
Increased
13,231
+90.2%
$20,2430.0%$76.50
20
2025-Q3
Decreased
6,957
-77.5%
$16,1050.0%$115.75
0
2025-Q2
Increased
30,926
+45.5%
$92,4690.0%$149.50
20
2025-Q1
New
21,262
-
$79,0950.0%$186.00
33

Other major holders of MDCX: Private Advisor Group, LLC, Verition Fund Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used